tirzepatide court Weight Loss Injections & Clinics Near You US judge denies injunction, restricting

Monisha Madhumita is a consultant dermatologist at Saveetha Medical College, Chennai

UK Evidence and Guidance Wegovy (semaglutide 2.4 mg) is a GLP-1 receptor agonist licensed by the MHRA for weight management in adults with obesity or overweight with comorbidities

Commercial insurance coverage for GLP-1 weight loss therapy remains below 15% in Mississippi employer plans as of 2026, meaning most privately insured patients still pay out-of-pocket or face prior authorization denials

PlexusDx also provides the Microdose GLP-1 Protocol at $129 monthly for patients seeking lower-intensity initiation

The cumulative cost of these workarounds is the effective toll the thicket imposes